Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SuperGen acquires rights to lucanthone for treatment of brain tumors

May 23, 2000

Cyclopentenone-based antitumor agents synthesized in China

May 23, 2000

Frequency of adverse events due to photodynamic therapy called into question

May 23, 2000

Vaccination with TAP1 gene promotes immune response to small cell lung cancer

May 23, 2000

Oxigene and Techniclone sign joint venture for vascular targeting therapies

May 23, 2000

NuChem selects NC-381 as lead anticancer agent

May 22, 2000

Antisense modulation of TRAF expression by new Isis compounds

May 22, 2000

PDL and Toagosei collaborate on SMART anti-VEGF development

May 22, 2000

Antisense oligonucleotides for modifying bcl-x expression in the Isis pipeline

May 19, 2000

SuperGen anticancer compound subject of new CRADA

May 19, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...